Farima Barmaki Rad is a physician and pharmacovigilance leader with extensive experience across clinical development and post-marketing safety. She specialises in training and coaching teams through practical workshops on pharmacovigilance topics, including end-to-end signal management, benefit–risk assessment (BRA), and the design, implementation, and evaluation of risk-minimisation measures (RMM). She draws on senior safety leadership roles at biopharmaceutical companies across the EU and on broad teaching experience delivering PV training for universities, health authorities, and professional societies.

PV professional with immense experience with critical PV processes gained through execution as well as its successful leadership and management. The key areas of Jan’s expertise are strategic consulting on full PV outsourcing including expert advice and guidance on the implementation of AI-powered safety systems, Safety data mining in global databases, ICSR Management, EV and XEVMPD maintenance, EU QPPV activities, signal management, PSMF development/maintenance, medical writing, and audits/inspections.

Vojtech is a qualified expert in drug safety and pharmacovigilance with extensive experience gained through working on different positions across all PV areas. The wide exposure to global clients (both sponsors and MAHs) has helped him to gain a comprehensive overview of critical PV processes and systems. Vojtech’s main expertise is advance pharmacovigilance consulting, EU QPPV activities, signal management, ICSR management, EudraVigilance support, XEVMPD/ISO IDMP, PV auditing and medical writing.

Eleni Savvaidou currently serves as Signal Management Lead at the Pharmacovigilance Office of the European Medicines Agency (EMA). She brings over 10 years of experience in pharmacovigilance, gained both within the pharmaceutical industry in Europe and at EMA. She holds degrees both in Chemistry and Pharmacy, providing a strong scientific foundation for her work in drug safety and regulatory science.